Barclays PLC American Depositary Receipts (ADR) (BCS) represents class A shares of the UK's global financial services provider, Barclays PLC. The company, headquartered in London, stands as one of the oldest and most widely respected banking organizations worldwide. Originating in the late 17th century, Barclays has steadily grown over the past three centuries to establish itself as a leading provider in personal, corporate, and investment banking.
The Barclays PLC ADR is traded on the New York Stock Exchange under the ticker symbol 'BCS.' As an ADR, it allows investors in the United States to invest in shares of foreign companies that might otherwise be difficult or expensive to own. Each Barclays PLC ADR represents four ordinary shares of Barclays PLC, and the price of BCS ADR fluctuates with changes in Barclays' stock price, providing an effective instrument for US investors to gain exposure to the UK financial sector.
Barclays Bank, the primary subsidiary, operates via two divisions: Corporate and Investment Bank (CIB) and Consumer, Cards, and Payments (CCP). CIB handles clients' most significant and complex banking needs, including financing, risk management, and advisory services. In contrast, CCP tends to the needs of individual consumers and smaller businesses, offering a broad range of products like deposits, loans, and credit cards.
The company has been recognized for its commitment to sustainable practices, earning inclusion in the Dow Jones Sustainability Index and the FTSE4Good Index. Also worthy of note is the company's responsible business practices, predominantly its Barclay's LifeSkills program, aimed at helping young people develop the skills needed for the 21st-century job market.
Despite facing several challenges, including controversies over the conduct of some executives and a major restructuring effort aimed at shedding unprofitable businesses, Barclays has remained resilient. As of the end of 2021, the bank posts solid financials, with a substantial market capitalization and boasting increased profits. Despite the ongoing impacts of global events such as Brexit and the COVID-19 pandemic, the company has shown an impressive ability to adapt and thrive in difficult market conditions.
In conclusion, Barclays PLC ADR (BCS) represents a stable, respected, and dynamic bank that provides a significant opportunity for US investors interested in gaining exposure to the UK financial sector.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Barclays shares have been among the worst performers on the FTSE 100, prompting a discussion on whether they are now a bargain. Despite mixed third-quarter results and a lower return on tangible equity compared to peers, analysts are optimistic, forecasting significant increases in earnings per share and RoTE over the next three years. With a current dividend yield of 3.6% and a consensus 12-month share price target 37% higher than today's value, the author suggests Barclays is an attractive investment for November.
The Rosen Law Firm is investigating potential securities claims on behalf of Barclays PLC (NYSE: BCS) shareholders due to allegations that Barclays may have issued misleading business information. This follows a Reuters article from February 27, 2026, which reported on the collapse of UK mortgage provider Market Financial Solutions Ltd (MFS) and Barclays' significant exposure to it. Investors who purchased Barclays securities are encouraged to inquire about joining a prospective class action to recover losses.
Barclays PLC has announced the admission of 1,950,128 new ordinary shares to trading on the Main Market of the London Stock Exchange. This brings the total number of shares admitted to trading to 13,307,527,424. The new shares are fungible with existing shares and the notification covers the period from October 1 to October 31, 2026.
Barclays Plc has disclosed a 5.02% indirect holding in Qiagen, comprising both real and potential voting rights, to Dutch financial regulators. This significant institutional stake, built through various financial instruments like shares, swaps, and convertible bonds, signals strong investor interest in Qiagen's stock. Qiagen is a Netherlands-based life sciences company listed on both Frankfurt and NYSE exchanges, specializing in sample and assay technologies for molecular diagnostics and research.
Barclays Plc is exploring credit insurance for over $10 billion in loans related to artificial intelligence infrastructure. This move aims to free up lending capacity for the bank amidst escalating funding demands from major cloud providers. While discussions are in early stages, Barclays reportedly seeks to offload more than half the credit risk on some AI-linked facilities to insurers.
Barclays PLC has notified Central Asia Metals PLC of a change in its major holdings, indicating that its total position in the company has fallen below the reportable threshold. The notification, completed on October 28, 2026, details that both direct voting rights and voting rights through financial instruments are now below the threshold, down from a previous notification of 5.04%.
Berenberg Bank has reiterated its Buy rating for Barclays (BCS), setting a price target of $33.50. This comes as Barclays reported strong quarterly revenues of $18.13 billion and a net profit of $2.5 billion for the quarter ending June 30, significantly up from the previous year. The analyst consensus for Barclays is currently a Moderate Buy with a target price of $20.63.
Barclays Plc reported strong Q3 earnings, with income up 3% and profit before tax rising 12%, leading to an 11.7% return on tangible equity. The bank also announced a new GBP 500 million share buyback and expects to achieve its greater-than-12% RoTE goal for 2026, driven by growth in stable income, U.K. lending, and digital transformation. Despite some near-term challenges in fixed income and higher costs due to investments, management remains confident in achieving its medium-term targets and addressing concerns about share valuation.